Clinical presentation of patients with late target lesion revascularization.
作者信息
Kaneda Hideaki
出版信息
Catheter Cardiovasc Interv. 2008 Nov 1;72(5):749. doi: 10.1002/ccd.21663.
PMID:18942148
Abstract
摘要
相似文献
1
Clinical presentation of patients with late target lesion revascularization.
Catheter Cardiovasc Interv. 2008 Nov 1;72(5):749. doi: 10.1002/ccd.21663.
2
Long-term follow-up of the First In Man experience with everolimus-eluting stents.
Catheter Cardiovasc Interv. 2010 Jun 1;75(7):1004-5. doi: 10.1002/ccd.22629.
3
Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
Catheter Cardiovasc Interv. 2008 Apr 1;71(5):599. doi: 10.1002/ccd.21568.
4
Stent fracture-unusual cause of DES restenosis.
Catheter Cardiovasc Interv. 2007 Jun 1;69(7):993-4. doi: 10.1002/ccd.21241.
5
The long-term results of the "Endeavor" stent.
Catheter Cardiovasc Interv. 2009 Dec 1;74(7):996-9. doi: 10.1002/ccd.22334.
6
Drug-eluting stent in saphenous vein graft lesions.
Catheter Cardiovasc Interv. 2008 Jun 1;71(7):894-5. doi: 10.1002/ccd.21615.
7
Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.
Catheter Cardiovasc Interv. 2008 Dec 1;72(7):944-9. doi: 10.1002/ccd.21731.
8
If I've heard it once, I've heard it (not yet) a hundred times.
Catheter Cardiovasc Interv. 2011 Mar 1;77(4):502. doi: 10.1002/ccd.22989.
9
Incidence and predictors of clinically driven target lesion revascularization from bare-metal stents to drug-eluting stents.
Catheter Cardiovasc Interv. 2007 Aug 1;70(2):184. doi: 10.1002/ccd.21293.
10
Drug-eluting balloon: the comeback kid?
Circ Cardiovasc Interv. 2009 Aug;2(4):352-8. doi: 10.1161/CIRCINTERVENTIONS.109.873703.
Zotero 插件